Format

Send to

Choose Destination
Trends Biotechnol. 2013 Jun;31(6):355-63. doi: 10.1016/j.tibtech.2013.03.005. Epub 2013 Apr 17.

Smelling the roses and seeing the light: gene therapy for ciliopathies.

Author information

1
Department of Pharmacology, University of Michigan, Ann Arbor, MI, USA.

Abstract

Alterations in cilia formation or function underlie a growing class of pleiotropic disorders termed ciliopathies. The genetic basis of ciliopathies is remarkably complex, with an incomplete but expanding list of more than 89 loci implicated in various disorders. Current treatment of ciliopathies is limited to symptomatic therapy. However, our growing understanding of ciliopathy genetics, coupled with recent advances in gene delivery and endogenous gene and transcript repair demonstrated thus far in tissues of the eye, nose, and airway, offers hope for curative measures in the near future. This review highlights these advances, as well as the challenges that remain with the development of personalized medicine for treating a very complex spectrum of disease, penetrant in a variety of organ systems.

PMID:
23601268
PMCID:
PMC3665744
DOI:
10.1016/j.tibtech.2013.03.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center